ECONOMICAL LOSSES DUE TO DISABLEMENTPARENTS CARRING FOR CHILDREN WITH ONCOHEMATOLOGICAL DISEASES
Author(s)
Ganieva D*1;Zhukovskaya E1, Spichak I2 1Federal Scientific Centre of Children Hematology, Oncology, Immunologyl, Moskow, Russia, 2Medical Academy, Chelyabinsk, Russia
Presentation Documents
OBJECTIVES: Socio-economic phenomena, caused by disease of children are reflected primarily in the formation of non-medical costs. Methodology for calculation of non-medical costs includes a number of parameters, including the cost of lost output by persons caring for children during the treatment period. METHODS: The study involved patients from Oncohematological Chelyabinsk Center for Children and Adolescents behalf of prof. V. Gerein been treated in the period from 2008 to 2013. Patient selection was random. The basic condition for inclusion in the study was the availability of data necessary to meet the costs. The number of patients at this stage of the study was already 42 people. Age at diagnosis was 9 months to 12 years, the median age of the patients was 6,4 ± 5,6 years. All of the patients were in the hospital with their parents of working age. In the calculations have been included: - GRP Chelyabinsk region (Gross Regional Product-14 USD per day per capita ) and GDP (Gross Domestic Product-44,4 USD per day per capita ), which amounted on average in 2008-2012. The formula for the calculation of total costs:E $ = Nd x GRP / GDP (Nd-the number of days of disability) RESULTS: Comparing the various cost components of treatment revealed that the indirect costs are 66% of the total amount of all expenses for medical treatment. State losses caused by non-working period of hospitalized for care people and non-produced Gross Regional Product are 7758,5 ± 1076,1 USD per capita. Losses of GDP are 21449,6 ± 3748,8 USD per capita. CONCLUSIONS: The formation of regional budgets should be done with consideration of big loss connected with disability of people hospitalized for the care of the a sick child, adjusted for and with GRP/GDP taken into account of big potion non-medical costs .
Conference/Value in Health Info
2013-11, ISPOR Europe 2013, The Convention Centre Dublin
Value in Health, Vol. 16, No. 7 (November 2013)
Code
PCN215
Topic
Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes
Disease
Oncology, Pediatrics